Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
Engin Berber's dataset contains serological measurements from a three-season study of influenza vaccine effectiveness. The data includes hemagglutination inhibition (HAI) titers from 1,328 participants aged 9–89 years who received one of six vaccine types between 2022–2025. It tracks seroprotection and seroconversion rates before and after vaccination, analyzing outcomes by age group and vaccine platform.
Data is provided in XLSX format; requires software capable of reading Excel files.